Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT29).
The time course of internalization of radioiodinated vasoactive intestinal peptide (VIP) in HT29 cells was obtained using the technique of acetic acid removal of cell-surface-bound peptide. Even after 10 min incubation at 37 degrees C, 125I-VIP, initially bound on the HT29 cell surface, was compartmentalized within the cells. During the same time, degraded radioactive material was released by cells in the incubation medium. Localization of internalized 125I-VIP was investigated using two different subcellular fractionation techniques. 10 min after the onset of internalization, 125I-VIP labelling was found in intermediate structures and 10 min later the bulk of the radioactivity was detected in a low-density fraction containing very large lysosomes with a multivesicular aspect. The lysosomotropic agent NH4Cl appeared to inhibit 125I-VIP internalization, degradation and appearance of radiolabelled peptide in the large lysosomes in a time-dependent manner. Moreover, the effect of NH4Cl resulted in an accumulation of radioactive material in fractions containing microsomal structures. On the other hand, bacitracin, together with methylamine, highly enhanced 125I-VIP labelling in a membrane fraction, suggesting that these agents possibly act on a cell surface component of HT29 cells. These results support the conclusion that in HT29 cells, prelysosomal structures and large secondary lysosomes are probably part of the intracellular pathway of internalized VIP.
D000230:Adenocarcinoma / Q000378:metabolism; D000643:Ammonium Chloride / Q000494:pharmacology; D001414:Bacitracin / Q000494:pharmacology; D001692:Biological Transport; D002451:Cell Compartmentation; D002458:Cell Fractionation / Q000379:methods; D002460:Cell Line; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008247:Lysosomes / Q000378:metabolism; D008744:Methylamines / Q000494:pharmacology; D013696:Temperature; D013997:Time Factors; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism*
D008744:Methylamines; D000643:Ammonium Chloride; D001414:Bacitracin; D014660:Vasoactive Intestinal Peptide; C027451:methylamine